Home > Press > Dr. Andrey Zarur Joins Kodiak Venture Partners
- Life sciences and high technology expert will focus on investing at the intersection of healthcare and IT -
Dr. Andrey Zarur Joins Kodiak Venture Partners
WALTHAM, MA | Posted on February 26th, 2007
Dr. Andrey Zarur has joined Kodiak Venture Partners, a seed and early stage venture capital firm, as General Partner. Zarur will source deals and support Kodiak portfolio companies within the intersection of the healthcare and high technology markets.
Recent years have seen a significant market emerge as a result of the convergence of life sciences and information technology disciplines. Kodiak recognizes this fast-growing market as the evolution of traditional investment areas such as IT and IT-related software and services as they begin to propagate into the healthcare and medical devices markets. The concentration of world class academic centers and teaching hospitals, coupled with a fertile ground for new ventures in these segments, make the Greater Boston area especially attractive for investing in companies focusing on convergence of healthcare and IT. Kodiak has made two investments in this area, ALIS (acquired by Carl Zeiss SMT in July 2006) and Cambridge Devices.
"I am thrilled to join Kodiak and spearhead entry into this exciting market," said Zarur. "The firm's dedication to early stage investing, strong entrepreneurial focus and dynamic team position us for success."
Andrey Zarur, Ph.D., has over 15 years of operating and investing experience. He joins Kodiak from BioProcessors, where he was founder and CEO. Prior to BioProcessors, Zarur served as an executive, investor or board member of over ten startups in areas including bioinformatics, genomics, medical devices, nanotechnology-derived materials and energy systems. He currently serves on the scientific advisory boards of Anecova and StemLife, and serves on the boards of directors of BioProcessors and Cambridge Devices (a Kodiak portfolio company). Zarur is also a director of Infantia, a foundation that provides education and board to underprivileged children in developing countries.
Zarur has earned several prestigious academic and management awards, authored over 20 articles in peer-reviewed journals, counts over 100 issued and pending patents to his name, and lectures at the Sloan School of Management at the Massachusetts Institute of Technology (MIT). He earned a B.Sc. in chemical engineering from the National University of Mexico, and a M.Sc.B. and a Ph.D. in chemical engineering from MIT.
"We have seen the evolution of the IT market over the past few funds, and decided to evolve with it by adding these converging disciplines into our investing focus," said Lou Volpe, Managing General Partner, Kodiak Venture Partners. "We have known and interacted with Andrey for several years and view him as the perfect complement to the Kodiak team—he brings the operational and technological expertise, and hands-on approach of all our partners into investments in these areas."
About Kodiak Venture Partners
Kodiak Venture Partners is a Waltham, Mass.-based venture capital firm focused on seed and early stage investments in emerging communications/wireless, semiconductor/equipment, software/services and Internet/new media companies. With a focus in the eastern regions of the U.S. and Canada, Kodiak establishes relationships with entrepreneurs seeking market success. Kodiak’s investment partners are successful high-technology business entrepreneurs who take a hands-on approach to building market leaders.
For more information, please click here
Vicki Sakakeeny, 011 506 342 3877
Kodiak Venture Partners
Liz Neal, 781-684-0222
Copyright © Business Wire
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Harris & Harris Group Notes the Receipt of Proceeds From the Sale of Molecular Imprints' Semiconductor Business to Canon April 22nd, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Characterizing inkjet inks: Malvern Instruments presents new rheological research April 23rd, 2014
NanoSafe, Inc. announces the addition of the Labconco Protector® Glove Box to its NanoSafe Tested™ registry April 23rd, 2014
Study finds long-term survival of human neural stem cells transplanted into primate brain April 23rd, 2014
High-Performance, Low-Cost Ultracapacitors Built with Graphene and Carbon Nanotubes: Future devices based on technology could bridge gap between batteries and conventional capacitors in portable electronics and hybrid electric vehicles April 23rd, 2014
Nanobiotix Appoints Thierry Otin as Head of Manufacturing and Supply April 15th, 2014
Industry Veteran Fergus Clarke Joins Picodeon as CEO: Appointment comes as Picodeon prepares for growth April 8th, 2014
Peter B. Littlewood appointed Director of Argonne National Laboratory March 26th, 2014
Global 450 consortium announces new general manager of internal operations: TSMC’s Cheng-Chung Chien Receives Unanimous Support, Brings History of Innovation and Efficiency to Global Consortium of Companies Driving Industry Transition to 450mm Wafer Technology March 26th, 2014